Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (20)

2022

  1. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up

    European Urology

2020

  1. Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies

    Frontiers in Oncology, Vol. 10

  2. Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression

    Journal of Urology

2019

  1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

  2. Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

    Scientific Reports, Vol. 9, Núm. 1

  3. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

2018

  1. The Ras-related gene ERAS is involved in human and murine breast cancer

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer

    Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399

  2. Epigenetic mutations and cancer therapy Effectiven(EZH2)

    Translational Cancer Research

  3. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

    Oncotarget, Vol. 8, Núm. 18, pp. 30410-30421

  4. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer

    Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542

  5. UroMark—a urinary biomarker assay for the detection of bladder cancer

    Clinical Epigenetics, Vol. 9, Núm. 1

2016

  1. Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development

    Oncotarget, Vol. 7, Núm. 46, pp. 75712-75728

  2. RNA Detection in Urine: From RNA Extraction to Good Normalizer Molecules

    Journal of Molecular Diagnostics, Vol. 18, Núm. 1, pp. 15-22

2015

  1. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

    Oncotarget, Vol. 6, Núm. 39, pp. 42258-42275

  2. Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer

    Clinical Epigenetics, Vol. 7, Núm. 1

  3. EZH2 in bladder cancer, a promising therapeutic target

    International Journal of Molecular Sciences, Vol. 16, Núm. 11, pp. 27107-27132

  4. NOTCH pathway inactivation promotes bladder cancer progression

    Journal of Clinical Investigation, Vol. 125, Núm. 2, pp. 824-830

  5. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors

    Molecular Carcinogenesis, Vol. 54, Núm. 7, pp. 566-576

2014

  1. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer

    Cancer Research, Vol. 74, Núm. 22, pp. 6565-6577